Jiangsu Aidea Pharmaceutical Hits Day High with 10.04% Surge

Jiangsu Aidea Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 10.04% on July 1, 2026. The stock reached an intraday high of CNY 14.29, marking a notable achievement for the small-cap company within the Pharmaceuticals & Biotechnology sector. In terms of performance metrics, Jiangsu Aidea's one-day gain stands in stark contrast to the China Shanghai Composite, which only saw a modest increase of 0.44%. Over the past week, the company's stock has surged by 14.03%, while the broader index has remained relatively flat with a 0.04% rise. However, the company has faced challenges over longer periods, with a one-month decline of 5.61% and a year-to-date drop of 13.41%. Despite these fluctuations, Jiangsu Aidea's market capitalization is currently at CNY 2,697 million. The company has shown a return on capital employed of 0.38%, indicating low profitability relative to its capital base. As the stock continues to navigate its market position, today's performance highlights a moment of recovery amidst broader trends.